Pfizer ups offer for AstraZeneca again, to $119B

U.S. drugmaker Pfizer announced that it has raised its offer for British rival AstraZeneca for a third time, hiking its stock-and-cash offer by 15 percent to $118.8 billion, or 70.73 billion pounds.